dollar-544956_1920darken.jpg

Governance Home

The Board of Directors of Nano Dimension Ltd. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Governance documents: Nano Dimension Code of Ethics

Governance Home

Board of Directors

Itschak Shrem
Chairman
Mr. Itschak Shrem has served as Chairman of the Board since April 2014. Mr. Shrem has more than 40 years of experience in financial markets and venture capital. He has been the Managing Director of Yaad Consulting 1995 Ltd. since 1995.

In 1993, Mr. Shrem founded Pitango Venture Capital Fund (formerly, Polaris) and served as a Partner of Pitango Funds I, II and III. In 1991, Mr. Shrem founded Dovrat Shrem Ltd., an investment banking, managing and technology company. Prior to that, he spent 15 years at Clal Israel Ltd., where he served in various capacities, including Chief Operating Officer and was responsible for capital markets and insurance businesses.

Mr. Shrem has been the Chairman of the Board of BreedIT Corp. since December 31, 2013. He has been a Director of Eden Spring Ltd. since October 2010. Mr. Shrem serves as a Director of Globe Oil Exploration Limited. He serves on the boards of a number of high-profile public institutions, including the Tel-Aviv Sourasky Medical Center and the Weizman Institute.

From 1991 to 2010, Mr. Shrem served as the Chairman of Leader Holdings and Investments Ltd. and Polar Communications Ltd., both TASE-listed companies engaged in investment banking and venture capital. Since 2004, Mr. Shrem has served as the Chairman of Sphera Funds Management Ltd. He served as a Director of Ormat Industries Ltd. from 2012 to 2015. He served as a Director of Retalix Ltd. from January 2008 to 2012.

Mr. Shrem holds a B.A. in Economics and Accounting from Bar-Ilan University and an M.B.A. from Tel-Aviv University, Israel.
Ofir Baharav
Director
Mr Ofir Baharav, has served on the board of directors since November 2015. Mr. Baharav, currently a partner in Stratus Venture Group, has served in a range of senior roles in the 3D printing sector and has extensive experience working with the venture capital community in Silicon Valley.

Mr. Baharav gained experience in the 3D printing industry as Vice President, Product Portfolio for Stratasys. He also founded Ejet and served as the company’s CEO for six years, where he raised $60m. Previously, Mr. Baharav founded and sold a healthcare technology company, Healinx, to McKesson for $50m.

Mr. Baharav is named on more than 10 software and hardware patents and holds an M.B.A. from Warwick Business School.
Amit Dror
Director
Mr. Amit Dror has served as our Chief Executive Officer and a director since August 2014. Mr. Dror co-founded Eternegy Ltd. in 2010 and served as its Chief Executive Officer and a director from 2010 to 2013.

Mr. Dror also co-founded the Milk & Honey Distillery Ltd. in 2012. He developed vast experience in project, account and sales management across a range of roles at ECI Telecom Ltd., Comverse, Eternegy Ltd. and Milk & Honey Distillery Ltd. Mr. Dror has a background that covers technology management, software, business development, fundraising and complex project execution.

Mr. Dror is a Merage Institute Graduate.
Simon Anthony-Fried
Director
Mr. Simon Fried has served as Chief Business Officer and a director since August 2014. Mr. Fried was a co-founder of Diesse Solutions Ltd., a project management, risk and marketing consultancy, and served as its Chief Executive Officer from 2004 to 2014.

Mr. Fried has worked as a risk management and corporate governance consultant to the Financial Services Authority in the United Kingdom and as a senior strategy consultant at Monitor Company, a Boston-based boutique strategy consulting firm.

Mr. Fried has a background that covers marketing and sales strategy, management, business development, financial services regulation, fundraising and c-suite consulting. Mr. Fried has worked extensively on global projects in both the B2B and B2C markets driving significant strategic change to global marketing organizations. He also currently serves as a director of the Milk & Honey Distillery Ltd.

Mr. Fried holds a B.Sc. in Experimental Psychology from University College London, a M.Sc. in Judgment and Risk from Oxford University and an M.B.A. from SDA Bocconi in Milan.
Sharon Fima
Director
Mr. Sharon Fima has served as Chief Technology Officer and a director since August 2014. Mr. Fima is a print technology development expert with many years in advanced R&D management positions, including digital printing technology, inkjet technology, 3D printer production and nano-silver ink development.

Mr. Fima's past positions include advanced research and development management at HP Indigo as the Integration Team Manager from 1999 to 2008, and with Xjet as the Production Manager from 2008 to 2009 and as an Integration R&D Manager from 2009 to 2013.
Irit Ben-Ami
External Director
Ms. Irit Ben-Ami has served on the board of directors as an external director since November 2012. Ms. Ben-Ami is a member of the Institute of Certified Public Accountants in Israel as well as the Israel Bar Association. Ms. Ben-Ami founded the law office of Pitaro-Ben Ami in 2007 and was a partner there until 2009. Ms. Ben-Ami currently serves as member of the board of directors of several public companies, including the Hagag Group Real Estate Entrepreneurship Ltd. (TASE:HGG) since 2011, Nadlans Ltd. (TASE:NDLS) since 2010, Netz United States HY Ltd. (TASE:NEZU) since 2012, BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV; TASE: BNDX) since 2008 and Medivie Therapeutic Ltd. (TASE:MDVI) since 2014.

Ms. Ben-Ami holds a LL.B., cum laude, from Sha’arei Mishpat College, a B.A., with honors in Economics and Accounting from Haifa University and an M.H.A. in Health Systems Management from Ben Gurion University. She was engaged in the past in academic aspects of labor law and corporate law as a practitioner at Bar Ilan University, Ben Gurion University and at the Sha’arei Mishpat College.
Roni Kleinfeld
External Director
Mr. Roni Kleinfeld has served on the board of directors as an external director since November 2012. He has over 25 years of experience as a chief executive officer of both public and private companies. He was the CEO of Maariv Holdings Ltd. from 1993 to 2002, the CEO of Hed Artzi Records Ltd. from 2002 to 2007, the CEO of Maariv Modiin Publishing House Ltd. from 2007 to 2010 and the CEO of OMI Ltd. from 2010 to 2011.

Mr. Kleinfeld has also served as a director of many companies over the past ten years, including: Excite Ltd. from April 2007 to April 2011, Makpel Ltd. from July 2007 to March 2010, Elbit Imaging Ltd. (NASDAQ: EMITF) since May 2010, Elran Ltd. since July 2010, Dancher Ltd. from April 2012 to January 2014, Mendelson Ltd. since 2012, White Smoke Ltd. since June 2012, Cofix Group Ltd. since April 2015 and Edri – El Ltd. since July 2015.

Mr. Kleinfeld has a B.A. in Economics from the Hebrew University in Jerusalem.
Abraham Nahmias
Director
Mr. Abraham Nahmias has served on the board of directors since August 2014. Mr. Nahmias has been a managing partner of the Nahmias-Grinberg C.P.A (Isr.) since 1985.

Mr. Nahmias currently serves as a director with the following companies: Rotshtein Real Estate Ltd. since 2007, Orad Ltd. since 2012, Allium Medical Solutions Ltd. since 2014 and Cellect Biomed Ltd. since July 2014.

Mr. Nahmias has a B.A. in Economy and Accountancy from Tel Aviv University and is a certified public accountant in Israel.
Avi Reichental
Director
Reichental served as president, chief executive officer and director at 3D Systems (NYSE: DDD) for more than a decade. Under his leadership, 3D Systems emerged as a formidable global 3D-printing provider, growing revenue by more than six-fold and increasing market valuation by more than twelve-fold.

Mr. Reichental currently serves as general partner at OurCrowd First, Israel’s most active early-stage venture fund, focused on seeding and scaling high-tech companies. Additionally, he is the founder, chairman and chief executive officer of XponentialWorks, a venture investment, advisory and product development company.

From 1981 to 2003, Mr. Reichental held senior executive leadership positions with Sealed Air (NYSE: SEE), where he also served as corporate officer for more than a decade. For the past two years, Reichental sat on the board of directors of Harman International (NYSE: HAR), a leading provider of connected products, until its recent acquisition by Samsung Electronics.
Eli Yoresh
Director
Mr. Eli Yoresh has served on the board since March 2014. Mr. Yoresh is a seasoned executive with over 15 years of executive and financial management experience, primarily with companies across the financial, technology and industrial sectors.

Since October 2010, Mr. Yoresh has served as a director and Chief Financial Officer at Asia Development (A.D.B.M) Ltd. (TASE:ASDV), and as a director at Proteologics Ltd. (TASE:PRTL) since September 20, 2013. Mr. Yoresh served as the Chief Executive Officer of Tomcar Global Holdings Ltd., a global manufacturer of off-road vehicles, from 2005 to 2008.

Mr. Yoresh served as a director at Greenstone Industries Ltd. (TASE: GRTN) from January 2013 to June 2015, and as the Chairman of both Gefen Biomed investments Ltd. (TASE: GEFEN) from April 2013 to July 2015 and Zmicha Investment House Ltd. (TASE: TZMI-M) from February 2013 to July 2015.

Mr. Yoresh holds a B.A. in Business Administration from the College of Management in Israel and an M.A. in Law from Bar-Ilan University in Israel. Mr. Yoresh is a certified public accountant in Israel.

Advisory Board

Prof. Shlomo Magdassi
Professor Shlomo Magdassi is a professor of chemistry at the Casali Center for Applied Chemistry, the Institute of Chemistry and the Center for Nanoscience and Nanotechnology at the Hebrew University of Jerusalem, Israel. His research focuses on colloid science, and in particular on formation, formulation and applications of novel micro and nanoparticles. These particles can be used as active components in functional inks and coating, for example light absorbing particles for solar energy devices, and metal nanoparticles and CNTs for 2D and 3D printing. He is the editor of three books, among them The The Chemistry Of Inkjet Inks.

In addition to his scientific publications, he also has various inventions on applications of colloids in industrial products. Based on these inventions, some commercial activities evolved and led to worldwide sales and establishing new companies. Magdassi received his B.Sc., MSc. and Ph.D. degrees in chemistry from the Hebrew University of Jerusalem.
Zeev Bregman
Zeev Bregman was President & Chief Executive Officer of Nice Systems (NASDAQ: NICE), a global software company, from 2009 to 2014. NICE is a market leader in analytics-based solutions for customer experience, financial risk and security. Previously, he served as the CEO of Comverse from 2001 to 2007 and was responsible for the company’s growth and transformation into a global technology leader.

Bregman joined Comverse in 1987 and served in several key positions before becoming CEO including Vice President and Head of the EMEA division, Vice President and Head of the Messaging division and Chief Operating Officer.
Ilan Atias
Mr. Ilan Atias, currently the founder managing partner at Keren Technologies, has led international business activities alongside major PE funds. In 2009, Mr. Atias co-founded InnoSave, a company in the field of energy savings for industrial electric motors, and served as its Chief Executive Officer. He was the winner of Ernst & Young’s “Israeli Entrepreneur of the Year” in 2005.

In 1995, Mr. Atias co-founded PowerDsine and served as its President and CTO. PowerDsine had a successful IPO on the NASDAQ and was later acquired by Microsemi Inc. for $245M. Earlier in his career, Mr. Atias acquired Y. Wallish Ltd. – an electronic components trader, which he co-managed and sold, increasing its valuation tenfold. Mr. Atias served as an electronic engineer in the IDF. He was awarded “The Israel Defense Prize” by the President of Israel in 1991.

Mr. Atias holds a B.S.c in Electronic Engineering, with honors, from the Technion, Haifa and a M.B.A from Tel-Aviv University.
metals_4.jpg

Contact Information

Nano Dimension Ltd.

2 Ilan Ramon St.

Ness-Ziona Science Park

972 73 750 9142

 

Investor Relations

Miri Segal Scharia

MS-IR LLC

917-607-8654

msegal@ms-ir.com 

Transfer Agent

BNY Mellon

101 Barclay Street, 22nd Floor

New York, NY 10286

212-815-2892

www.adrbnymellon.com  

Copyright 2017, © S&P Global Market Intelligence  Terms of Use